Company profile: Genomind
1.1 - Company Overview
Company description
- Provider of neuropsychiatry-focused precision medicine solutions, including pharmacogenetic (PGx) testing to personalize medication dosing and choices, software to identify gene–drug and drug–drug interaction risks and suggest safer alternatives, expert consults for staff training and patient-specific consultations, population health risk stratification, and in-person, virtual, and self-paced education.
Products and services
- Pharmacogenetic (PGx) Testing: Produces genetic-profile–based guidance that personalizes medication dosing and selection using a patient's genetic profile to improve prescribing
- Precision Medicine Consults: Delivers patient-specific consultations with PharmD and PhD experts, including staff training and individualized support aligned to neuropsychiatric precision medicine
- Precision Medicine Software: Architects risk-based software that identifies gene and drug interaction risks and suggests safer alternatives for treatment decisions
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Genomind
NuGEN
HQ: United States
Website
- Description: Provider of innovative genomics sample preparation solutions enabling scientists to access true biology in all samples, independent of type, quality and amount, for analysis on leading analytical platforms, ensuring robust and reproducible results for researchers seeking to predict disease
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NuGEN company profile →
Advanced Cell Diagnostics
HQ: United States
Website
- Description: Provider of molecular pathology cell- and tissue-based diagnostic tests for personalized medicine, including RNAscope for single-molecule, high-specificity RNA detection in intact cells; BaseScope for detecting exon junctions and splice variants in FFPE tissue with morphological context; and miRNAscope for cell-type specific detection of miRNAs, siRNAs, and other small RNAs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Advanced Cell Diagnostics company profile →
Genoplan
HQ: Japan
Website
- Description: Provider of DNA testing and genetic analysis services, offering health risk prediction to support informed decisions, pregnancy genetic testing to identify genetic disorder risks for family planning, and traits & ancestry insights into characteristics and lineage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genoplan company profile →
Megazyme
HQ: Ireland
Website
- Description: Provider of analytical enzymes, chromogenic substrates, high-purity polysaccharides and colourimetric oligosaccharides; assay kits including Rapid Integrated Total Dietary Fiber and Lactose Assay; and Food Safety Division dehydrated culture media and diagnostic tests for foodborne bacteria, natural toxins, genetic modifications and allergens, serving laboratories in food & beverages, biofuel, animal feed, wine & brewing, dairy and cereals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Megazyme company profile →
Nightingale Health
HQ: Finland
Website
- Description: Provider of pioneering blood-testing services and proprietary blood analysis technology that delivers deep health insights, identifies disease risks from a single sample, and measures the effects of lifestyle interventions. Offers Nightingale Pro data platform for detecting population-level disease risks and preventative health needs, and biomarker analysis services for researchers across blood, urine, and dried blood spot samples.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nightingale Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Genomind
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Genomind
2.2 - Growth funds investing in similar companies to Genomind
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Genomind
4.2 - Public trading comparable groups for Genomind
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →